2005
Response of the Lung to Pulmonary Insulin Dosing in the Rat Model and Effects of Changes in Formulation, T. Cooper Woods, Bin Zhang, Frank Mercogliano, Steven M. Dinh, Diabetes Technology & Therapeutics, Volume 7, Number 3, 2005
2004
Oral Absorption Enhancement of Cromolyn Sodium Through Noncovalent Complexation. Xuan Ding, Parshuram Rath, Robert Angelo, Thomas Stringfellow, Elizabeth Flanders, Steven Dinh, Isabel Gomez-Orellana, and Joseph R. Robinson. Pharmaceutical Research, Vol. 21, pp. 2196-2206 (2004)
Patentability issues of 3D protein structures. Gabriela Mustata, Drug Discovery Today, July 2004
Advances in the oral delivery of heparin from solid dosage forms using Emisphere’s eligen® oral drug delivery technology. Shingai Majuru, Drug Delivery Technology, October 2004
The Physiological rationale for Oral Insulin Administration. Ehud Arbit, Diabetes Technology & Therapeutics, Volume 6, 2004
2003
Oral Delivery of Macromolecules: A Perspective Using the eligen® technology. Brahma N. Singh, and Shingai Majuru. Drug Delivery Technology June 2003
Challenges for the Oral Delivery of Macromolecules. Michael Goldberg, and Isabel Gomez-Orellana. Nature Review April 2003
Oral Heparin Administration with a Novel Delivery Agent (SNAC) in Healthy Volunteers and Patients Undergoing Elective Total Hip Arthroplasty. S.D. Berkowitz, V.J. Marder, G. Kosutic, R.A. Baughman, Jr. Journal of Thrombosis & Haemotosis 2003
back to top
2002
Oral Insulin: Pharmacokinetics and Pharmacodynamics of Human Insulin Following Oral Administration of an Insulin/Delivery Agent Capsule Healthy Volunteers. Richat Abbas, Andrea Leone-Bay, Rajesh Agawal, Shingai Majuru, Paul Rolan, Cyril Clarke, Colin Scott, Ehud Arbit and Robert A. Baughman, Jr. Diabetes, Journal of the American Diabetes Association, June 2002, Volume 51, A48, S. 2.
Bio-Availability and Biological Efficacy of a New Oral Formulation of Salmon Calcitonin in Healthy Volunteers. Journal of Bone Mineral Research, 2002
Oral Cromolyn: Pharmacokinetics of Cromolyn Sodium Delivered Orally in Healthy Volunteers. Richat Abbas, Robert A. Baughman, S. De Bruyn, Donald Sarubbi, and Ehud Arbit. Allergy - European Journal of Allergy and Clinical Immunology, S. 73, Volume 57, 338, 2002
Oral Delivery of Cromolyn: Bioavailability and Bioactivity After Oral Administration in Animal Models. Don Sarubbi, Puchan Liu, Ehud Arbit, William Abraham, Steve Dinh, American Academy of Allergy & Asthma Institute Conference, New York NY, March 2002
Physical Properties of Compounds Promoting Oral Delivery of Macromolecular Drugs. R. Z. Desamero, H. Cheng, S. Cahill, M. Girvin, H. Deng, R. Callender, P. Rath, B. Variano and J.E. Smart. Biopolymers, 2002; 67(1): pp 26-40.
Interactions of Amidated Acids with Heparin. R. Z. Desamero; H. Cheng; S. Cahill; M. Girvin: H. Deng; R. Callender; P. Rath; B. Variano and J.E. Smart. Biopolymers, 2002; 67(1): pp 41-48.
Pathway of Oral Absorption of Heparin with Sodium N-[8-(2-Hydroxybenzoyl)Amino]Caprylate. Dmitry Malkov, Huai-zhen Wang, Steven Dinh, and Isabel Gomez-Orellana. Pharmaceutical Research, Vol. 19, No. 8, pp. 1180-1184 2002
Mechanism of Oral Absorption of Insulin with EMISPHERE® Drug Delivery Agents. Dmitry Malkov, Huai-zhen Wang, Robert Angelo, Heather Tang, Steven Dinh, and Isabel Gomez-Orellana. 29th Annual Meeting of the Controlled Release Society Proceedings p. 679 2002
back to top
2001
Oral delivery of biologically active parathyroid hormone. Andrea Leone-Bay, Masahiko Sato, Duncan Paton,; Ann H. Hunt, Donald Sarubbi, Monica Carozza, James Chou, James McDonough, Robert A. Baughman, Jr. Pharmaceutical Research, (2001), 18(7), 964-970.
In-Vitro Evaluation of I with Human CYP450 Isoenzymes. Catherina M. O’Shaughnessy, Lorraine M. Rusch, Richat Abbas, Liangfu Chen and Robert A. Baughman, Jr. Drug Metabolism Review, Vol. 33, 381, 2001
Interspecies Comparison of SNAC and SNAD in vitro Plasma Protein Binding. Lorraine M. Rusch, Richat Abbas, Catherina M. O’Shaughnessy, Liangfu Chen, and Robert A. Baughman, Jr. Drug Metabolism Review, Vol. 33, 233, 2001
Pharmacokinetics (PK) and Pharmacodynamics (PD) of SNAD/Heparin in Rhesus Monkeys. Richat Abbas, A.Chaouki Zerouala, and Robert A. Baughman, Jr. Drug Metabolism Review, Vol. 33, 400, 2001
Absolute Bioavailability of SNAD and Pharmacokinetics of SNAD/Heparin in Rats. Richat Abbas, Alda Pombo-Gentile, and Robert A. Baughman, Jr. Drug Metabolism Review, Vol. 33, 124, 2001
Facilitation of Pulmonary Insulin Absorption by H-MAP: PK & PD in Rats. Pharmaceutical Research, December 2001
Immediate and Short-Term Cellular and Biochemical Responses to Pulmonary Single Dose Studies of Insulin and H-MAP. Pharmaceutical Research, December 2001
Oral Delivery of Biologically Active Parathyroid Hormone. Pharmaceutical Research, July 2001
Oral Heparin Prevents Neointimal Hyperplasia After Arterial Injury: Inhibitory Potential Depends on Type of Vascular Injury. Circulation, 2001
back to top
